Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0752347 (
Dementia with Lewy bodies
)
1,653
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Dementia with Lewy bodies
(
DLB
) represents the second most frequent type of neurodegenerative dementia in the elderly. Although most patients have sporadic
DLB
, a limited number of
DLB
families have been described, suggesting that genetic factors may contribute to
DLB
pathogenesis. Here, we describe a three-generation Belgian family with prominent dementia and parkinsonism, consistent with a diagnosis of
DLB
, that was autopsy confirmed for the index patient. In a genome-wide scan and subsequent finemapping of candidate loci we obtained significant linkage to 2q35-q36 (Z = 3.01 at D2S1242). Segregation analysis defined a candidate region of 9.2 Mb between D2S433 and chr2q36.3-8, adjacent to the previously reported
PARK11
locus. In addition, haplotype sharing studies in another
DLB
family of close geographical origin with similar clinical and neuropathological features highlighted the specificity of a 2q35-q36 haplotype harbouring a pathogenic mutation that causes
DLB
in the Belgian family. So far, extensive sequence analysis of five candidate genes within the 2q35-q36 region has not revealed a disease-causing mutation. Together, our data re-emphasize the genetic heterogeneity of
DLB
, and strongly support the existence of a gene for familial
DLB
on 2q35-q36. Once identified this will be the first novel causal gene for
DLB
and can be expected to open new avenues for biological studies of the disease process.
...
PMID:A novel locus for dementia with Lewy bodies: a clinically and genetically heterogeneous disorder. 1768 82